A Bangalore-based start-up has developed a novel, point-of-care Electrochemical ELISA test that enables fast and accurate estimation of total antibody concentration of COVID -19 in clinical samples.<br />”&nbsp;<br />”PathShodh Healthcare, the start-up incubated at the Society for Innovation and Development, Indian Institute of Science, has made a very significant breakthrough to develop the first of its kind, semi-quantitative Electrochemical ELISA test for COVID-19 IgM and IgG antibodies.<br />”&nbsp;<br />”While Qualitative analysis detects constituent elements in the sample, semiquantitative analysis gives an approximate estimation of their concentrations.<br />”&nbsp;<br />”PathShodh has received the license to manufacture for sale from the Central Drugs Standard Control Organisation.<br />”&nbsp;<br />”<span style="color: #222222;">This novel technology and product was supported by the Department of Science and Technology under its initiative on Centre for Augmenting WAR with COVID-19 Health Crisis.</span><br />